Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
6.68
+0.03 (0.45%)
Jan 28, 2026, 2:15 PM EST - Market open
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $34.6 million as of January 28, 2026.
Market Cap
34.60M
Enterprise Value
42.69M
1-Year Change
n/a
Ranking
Category
Stock Price
6.68
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $34.60M, a decrease of -12.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 34.44M | -1.34% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IceCure Medical | 45.70M |
| Cytosorbents | 43.95M |
| TELA Bio | 43.42M |
| NeuroOne Medical Technologies | 42.55M |
| Elutia | 40.47M |
| Baird Medical Investment Holdings | 38.19M |
| Modular Medical | 36.20M |
| Myomo | 35.43M |